Reprogramming gut bacteria as “living therapeutics”
Daily doses of synthetic biotics developed by startup Synologic may sense, treat metabolic diseases.
Daily doses of synthetic biotics developed by startup Synologic may sense, treat metabolic diseases.
Device that filters blood to prevent organ failure wins MIT Sloan Healthcare Innovations Prize.
MIT's Institute of Medical Engineering and Science is on the front lines of efforts to diagnose and develop a vaccine against the emerging Zika virus.
Environmental management approaches may be key in combating mosquito-borne infectious diseases.
High-speed imaging shows how fluid breaks apart in air, may help identify super-spreaders.
Sensors that track inhaler use aim to keep asthma patients healthy, cut health care costs.
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
MIT researcher discusses a new study on correlations among medical problems.
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
New center will incorporate research on the study of aging in the Department of Biology, Picower Institute for Learning and Memory, and David H. Koch Institute for Integrative Cancer Research.
Hydrogen peroxide produced by some bacteria causes DNA double-strand breaks, cell suicide.
New research suggests ways to reduce the likelihood that individuals and groups will become infected with influenza.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.